BMI View: Pharmaceutical companies are facing far greater opportunities and challenges than
the Affordable Care Act (ACA). Healthcare reform in the US could have sought significant monetary
contributions from drugmakers, but this did not materialise in a meaningful se ..."
BMI View: Despite the botched rollout of the Affordable Care Act, we expect reform of the US healthcare
system to continue over the coming years, mainly due to the need to control growth in spending on medical
services. Implementation will not be smooth due to the law ..."
BMI View: Multinational drugmakers with higher exposure to the US pharmaceutical market will
outperform rivals with established presences in Western Europe and emerging markets. The former region
is under pressure from austerity-induced medicine price cuts, and many m ..."
BMI View: The necessity of reducing healthcare spending by both the public and private sectors in the US
is having a direct downward effect on prescription drug expenditure. The government, employers and
families can readily identify with medicine cost containment, but have dif ..."
BMI View: For years to come, the US pharmaceutical market will remain the most attractive to drugmakers. Considerable absolute sales figures and high expected growth are supported by a robust economy and political stability. Access to healthcare in general and medicines in partic ..."
Despite assertions from some stakeholders, the r e-election of Barack Obama as President of the United States is not bad news for pharmaceutical companies and medical device manufacturers, primarily because we expect continuation of existing policies that have generally been favo ..."
Despite assertions from some stakeholders, the re-election of Barack Obama as President of the United States is not bad news for pharmaceutical companies and medical device manufacturers, primarily because we expect continuation of existing policie ..."
BMI View: Regardless of who emerges victorious in the US presidential election in November 2012, the
country's healthcare system is set for further changes. Bloated spending on medical services is widely
acknowledged and will receive further attention during the ..."